NIKA PHARMACEUTICALS INC.

NIKA PHARMACEUTICALS INC.

OOTC:NIKA
0.35
USD
0.00
(0.00%)
0.00EPS
806.33MMarket Cap

Total Valuation

USD

As of June 30, 2026, NIKA PHARMACEUTICALS INC. carries a market capitalization of 806.33M, placing it among publicly traded companies globally. Its enterprise value stands at 806.33M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap806.33M
Enterprise Value806.33M

Share Statistics

As of June 30, 2026, NIKA PHARMACEUTICALS INC. has 1.05B shares outstanding.

Shares Outstanding1.05B

Valuation Ratios

These figures are as of June 30, 2026.

PB Ratio-2,427.39
P/TBV Ratio-2,427.39
P/FCF Ratio-11,643.39
P/OCF Ratio-11,643.39

Financial Position

As of June 30, 2026, NIKA PHARMACEUTICALS INC. maintains a current ratio of 0.03, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities.

Current Ratio0.03
Quick Ratio0.01

Financial Efficiency

These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -376.14, reflecting losses generated across the asset base.

Return on Assets (ROA)-376.14

Stock Price Statistics

USD

As of the close on October 28, 2026, NIKA PHARMACEUTICALS INC.'s stock has gained approximately 16.59% over the past 52 weeks.

52-Week Price Change16.59%
50-Day Moving Average0.43

Income Statement

USD

Over the twelve months ended June 30, 2026, NIKA PHARMACEUTICALS INC. generated - - in revenue and converted that into -78,141.00 in net income, yielding earnings per share of 0.00. EBITDA reached -78,141.00, while operating income came in at -78,123.00.

Operating Income-78,123.00
Pretax Income-78,141.00
Net Income-78,141.00
EBITDA-78,141.00
EBIT-78,141.00

Balance Sheet

USD

These figures are as of June 30, 2026. Total book value stands at -332,182.00, with working capital of -330,682.00 providing operational flexibility.

Cash & Cash Equivalents2,932.00
Net Debt-2,932.00
Equity (Book Value)-332,182.00
Working Capital-330,682.00

Cash Flow

USD

NIKA PHARMACEUTICALS INC. produced -69,144.00 in operating cash flow over the twelve months ended June 30, 2026.

Operating Cash Flow-69,144.00
Free Cash Flow-69,144.00

Dividends & Yields

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -0.01: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -0.01, meaning NIKA PHARMACEUTICALS INC. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Shareholder Yield-0.01
FCF Yield-0.01

Scores

As of June 30, 2026, NIKA PHARMACEUTICALS INC. has an Altman Z-Score of 81.92, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score81.92